BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 10825001)

  • 21. Suggestive linkage of familial primary cutaneous amyloidosis to a locus on chromosome 1q23.
    Lin MW; Lee DD; Lin CH; Huang CY; Wong CK; Chang YT; Liu HN; Hsiao KJ; Tsai SF
    Br J Dermatol; 2005 Jan; 152(1):29-36. PubMed ID: 15656797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytogenetic, spectral karyotyping, fluorescence in situ hybridization, and comparative genomic hybridization characterization of two new secondary leukemia cell lines with 5q deletions, and MYC and MLL amplification.
    Knutsen T; Pack S; Petropavlovskaja M; Padilla-Nash H; Knight C; Mickley LA; Ried T; Elwood PC; Roberts SJ
    Genes Chromosomes Cancer; 2003 Jul; 37(3):270-81. PubMed ID: 12759925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of the chromosomal region 5q11-q31 in the myeloid cell line HL-60: characterization by comparative genomic hybridization and fluorescence in situ hybridization.
    Shipley J; Weber-Hall S; Birdsall S
    Genes Chromosomes Cancer; 1996 Mar; 15(3):182-6. PubMed ID: 8721684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Constitutional t(5;7)(q11;p15) rearranged to acquire monosomy 7q and trisomy 1q in a patient with myelodysplastic syndrome transforming to acute myelocytic leukemia.
    Ganly P; McDonald M; Spearing R; Morris CM
    Cancer Genet Cytogenet; 2004 Mar; 149(2):125-30. PubMed ID: 15036888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterogeneity of structural abnormalities in the 7q31.3 approximately q34 region in myeloid malignancies.
    González MB; Gutiérrez NC; García JL; Schoenmakers EF; Solé F; Calasanz MJ; San Miguel JF; Hernández JM
    Cancer Genet Cytogenet; 2004 Apr; 150(2):136-43. PubMed ID: 15066321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel pheochromocytoma susceptibility loci identified by integrative genomics.
    Dahia PL; Hao K; Rogus J; Colin C; Pujana MA; Ross K; Magoffin D; Aronin N; Cascon A; Hayashida CY; Li C; Toledo SP; Stiles CD;
    Cancer Res; 2005 Nov; 65(21):9651-8. PubMed ID: 16266984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strong indication for a breast cancer susceptibility gene on chromosome 8p12-p22: linkage analysis in German breast cancer families.
    Seitz S; Rohde K; Bender E; Nothnagel A; Kölble K; Schlag PM; Scherneck S
    Oncogene; 1997 Feb; 14(6):741-3. PubMed ID: 9038382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conventional and molecular cytogenetic findings of myelodysplastic syndrome patients.
    Yilmaz Z; Sahin FI; Kizilkilic E; Karakus S; Boga C; Ozdogu H
    Clin Exp Med; 2005 Jul; 5(2):55-9. PubMed ID: 16096854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations with loss of heterozygosity of p53 are common in therapy-related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor prognosis.
    Christiansen DH; Andersen MK; Pedersen-Bjergaard J
    J Clin Oncol; 2001 Mar; 19(5):1405-13. PubMed ID: 11230485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of RUNX1/AML1 as a classical tumor suppressor gene.
    Silva FP; Morolli B; Storlazzi CT; Anelli L; Wessels H; Bezrookove V; Kluin-Nelemans HC; Giphart-Gassler M
    Oncogene; 2003 Jan; 22(4):538-47. PubMed ID: 12555067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chromosome 20 deletions in myelodysplastic syndromes and Philadelphia-chromosome-negative myeloproliferative disorders: characterization by molecular cytogenetics of commonly deleted and retained regions.
    Douet-Guilbert N; Basinko A; Morel F; Le Bris MJ; Ugo V; Morice P; Berthou C; De Braekeleer M
    Ann Hematol; 2008 Jul; 87(7):537-44. PubMed ID: 18350294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FISH investigation of 5q and 7q deletions in MDS/AML reveals hidden translocations, insertions and fragmentations of the same chromosomes.
    Lessard M; Herry A; Berthou C; Léglise MC; Abgrall JF; Morice P; Flandrin G
    Leuk Res; 1998 Apr; 22(4):303-12. PubMed ID: 9669835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical relevance of cytogenetics in myelodysplastic syndromes.
    Bernasconi P; Boni M; Cavigliano PM; Calatroni S; Giardini I; Rocca B; Zappatore R; Dambruoso I; Caresana M
    Ann N Y Acad Sci; 2006 Nov; 1089():395-410. PubMed ID: 17261783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequent loss of heterozygosity without loss of genetic material in acute myeloid leukemia with a normal karyotype.
    Gorletta TA; Gasparini P; D'Elios MM; Trubia M; Pelicci PG; Di Fiore PP
    Genes Chromosomes Cancer; 2005 Nov; 44(3):334-7. PubMed ID: 16015648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of balanced rearrangements of chromosome 6 in acute leukemia: clustered breakpoints in q22-q23 and possible involvement of c-MYB in a new recurrent translocation, t(6;7)(q23;q32 through 36).
    Sinclair P; Harrison CJ; Jarosová M; Foroni L
    Haematologica; 2005 May; 90(5):602-11. PubMed ID: 15921375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anatomy of the 5q- deletion: different sex ratios and deleted 5q bands in MDS and AML.
    Pedersen B
    Leukemia; 1996 Dec; 10(12):1883-90. PubMed ID: 8946926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A cryptic deletion in 5q31.2 provides further evidence for a minimally deleted region in myelodysplastic syndromes.
    MacKinnon RN; Kannourakis G; Wall M; Campbell LJ
    Cancer Genet; 2011 Apr; 204(4):187-94. PubMed ID: 21536236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Detection of common chromosome abnormalities in myelodysplastic syndrome with a panel fluorescence in situ hybridization].
    Shen Y; Xue Y; Li J; Pan J; Wu Y; Chen S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):160-3. PubMed ID: 12673589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delineation of the minimal commonly deleted segment and identification of candidate tumor-suppressor genes in del(9q) acute myeloid leukemia.
    Sweetser DA; Peniket AJ; Haaland C; Blomberg AA; Zhang Y; Zaidi ST; Dayyani F; Zhao Z; Heerema NA; Boultwood J; Dewald GW; Paietta E; Slovak ML; Willman CL; Wainscoat JS; Bernstein ID; Daly SB
    Genes Chromosomes Cancer; 2005 Nov; 44(3):279-91. PubMed ID: 16015647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Deletion of the long arm of chromosome 5 in patients with hematologic malignancies].
    Brezinová J; Zemanová Z; Michalová K
    Cas Lek Cesk; 2001 Feb; 140(2):43-6. PubMed ID: 11262906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.